Overview
Holy Name's gynecologic oncologists provide advanced medical and surgical treatments for patients with pre-cancerous conditions and cancer including:
Dr. Sharyn Lewin and Dr. Maria Schiavone are renowned gynecologic oncologists and two of the few physicians in North Jersey who provide both surgery and chemotherapy in one setting, eliminating the need to see additional physicians for gynecologic cancer treatment. They have expertise in hypertermic intraperitoneal chemotherapy (HIPEC), oral PARP inhibitors and sentinel lymph node mapping. They also specialize in genetic testing and counseling.
Patients receiving treatment for gynecologic cancers also have access to free integrative therapies such as massage, acupuncture, nutritional education, counseling support, guided imagery and yoga.
In addition to standard treatment protocols, Holy Name offers patients access to clinical trials, cutting-edge research, hereditary genetics and highly effective treatment options that include the following:
Robotic surgery is a minimally invasive procedure that utilizes the daVinci platform, which is a surgical system that includes a console and robotic arm with small tools attached. Surgeons are able to do extremely precise and complex procedures by controlling the arm with a computer while viewing enlarged 3-D images taken by a camera inserted into the body. Robotic surgery has the same advantages as laparoscopic surgery – less discomfort, shorter recovery time and a reduced risk of forming internal scar tissue - since it is performed through smaller cuts than open surgery.
Advanced laparoscopic surgery is a minimally invasive technique that allows the surgeon to operate through small incisions while looking at the targeted area magnified on a large monitoring screen. Procedures result in less discomfort and a shorter recovery time and reduce the chance of forming internal scar tissue, which can cause pain in the future.
Intraperitoneal chemotherapy, used in the treatment of ovarian cancer, involves administering chemotherapy drugs through a flexible tube inserted into the patient's abdomen. Studies have shown that patients given intraperitoneal chemotherapy have better outcomes than women who only received IV chemotherapy.
